Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies
This study is currently recruiting participants.
Study NCT00506805   Information provided by Pfizer
First Received: July 24, 2007   Last Updated: October 2, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
SNX-5422
Sponsors listed in this trial
Pfizer
Serenex, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services